Emory University in Atlanta has announced gifts totaling $23.7 million from Cox Enterprises and the James M. Cox Foundation to establish a program for the study and treatment of early declines in memory.
To be housed at the Emory Brain Health Center, the Mild Cognitive Impairment (MCI) Empowerment Program will focus on research, clinical care, caregiver support, and empowering patients to take an active role in their health and wellness. Often a precursor to Alzheimer's disease, MCI is characterized by a distinct, early decline in memory and the ability to think and affects up to 20 percent of Americans over the age of 65, a demographic cohort that is expected to double to 88.5 million by 2050.
In partnership with the Georgia Institute of Technology's Institute for People and Technology and the SimTigrate Design Lab in Georgia Tech's College of Design, the program will work to improve quality of life for MCI sufferers and their families and develop more effective, evidence-based therapies.
"The Cox gifts are allowing us to greatly accelerate our efforts to improve the lives of our patients and their families," said Allan Levey, director of the Goizueta Alzheimer's Disease Research Center at Emory. "The MCI Empowerment Program presents an unprecedented opportunity for us to fill a gap in research and care while developing innovations that can be used worldwide."